位置:首页 > 蛋白库 > MTG16_MOUSE
MTG16_MOUSE
ID   MTG16_MOUSE             Reviewed;         620 AA.
AC   O54972; Q7TND6; Q8BZS0;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   03-AUG-2022, entry version 137.
DE   RecName: Full=Protein CBFA2T3;
DE   AltName: Full=Eight twenty one protein 2;
DE   AltName: Full=MTG8-related protein 2;
DE   AltName: Full=Protein ETO-2;
GN   Name=Cbfa2t3; Synonyms=Cbfa2t3h, Mtgr2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Spleen;
RX   PubMed=10022820; DOI=10.1038/sj.onc.1202412;
RA   Davis J.N., Williams B.J., Herron J.T., Galiano F.J., Meyers S.;
RT   "ETO-2, a new member of the ETO-family of nuclear proteins.";
RL   Oncogene 18:1375-1383(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Cecum;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 401-620 (ISOFORMS 1/2).
RC   STRAIN=FVB/N; TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH HDAC1; HDAC2; HDAC3; HDAC6; HDAC8; NCOR1 AND
RP   NCOR2.
RX   PubMed=11533236; DOI=10.1128/mcb.21.19.6470-6483.2001;
RA   Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N.,
RA   Downing J.R., Meyers S., Hiebert S.W.;
RT   "ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with
RT   multiple histone deacetylases and binds mSin3A through its oligomerization
RT   domain.";
RL   Mol. Cell. Biol. 21:6470-6483(2001).
RN   [5]
RP   FUNCTION, INTERACTION WITH NCOR1, AND TISSUE SPECIFICITY.
RX   PubMed=15231665; DOI=10.1158/0008-5472.can-03-3689;
RA   Ibanez V., Sharma A., Buonamici S., Verma A., Kalakonda S., Wang J.,
RA   Kadkol S., Saunthararajah Y.;
RT   "AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor
RT   corepressor, an effect that impairs granulocyte differentiation.";
RL   Cancer Res. 64:4547-4554(2004).
RN   [6]
RP   FUNCTION, AND IDENTIFICATION IN TAL-1 COMPLEX.
RX   PubMed=16407974; DOI=10.1038/sj.emboj.7600934;
RA   Goardon N., Lambert J.A., Rodriguez P., Nissaire P., Herblot S.,
RA   Thibault P., Dumenil D., Strouboulis J., Romeo P.-H., Hoang T.;
RT   "ETO2 coordinates cellular proliferation and differentiation during
RT   erythropoiesis.";
RL   EMBO J. 25:357-366(2006).
RN   [7]
RP   INDUCTION.
RX   PubMed=17533052; DOI=10.1016/j.exphem.2007.03.002;
RA   Okumura A.J., Peterson L.F., Lo M.-C., Zhang D.-E.;
RT   "Expression of AML/Runx and ETO/MTG family members during hematopoietic
RT   differentiation of embryonic stem cells.";
RL   Exp. Hematol. 35:978-988(2007).
CC   -!- FUNCTION: Transcriptional corepressor which facilitates transcriptional
CC       repression via its association with DNA-binding transcription factors
CC       and recruitment of other corepressors and histone-modifying enzymes.
CC       Can repress the expression of MMP7 in a ZBTB33-dependent manner.
CC       Reduces the protein levels and stability of the transcriptinal
CC       regulator HIF1A; interacts with EGLN1 and promotes the HIF1A prolyl
CC       hydroxylation-dependent ubiquitination and proteasomal degradation
CC       pathway. Contributes to inhibition of glycolysis and stimulation of
CC       mitochondrial respiration by down-regulating the expression of
CC       glycolytic genes including PFKFB3, PFKFB4, PDK1, PFKP, LDHA and HK1
CC       which are direct targets of HIF1A (By similarity). Regulates the
CC       proliferation and the differentiation of erythroid progenitors by
CC       repressing the expression of TAL1 target genes (PubMed:16407974). Plays
CC       a role in granulocyte differentiation (PubMed:15231665).
CC       {ECO:0000250|UniProtKB:O75081, ECO:0000269|PubMed:11533236,
CC       ECO:0000269|PubMed:15231665, ECO:0000269|PubMed:16407974}.
CC   -!- SUBUNIT: Heterodimer with RUNX1T1 and CBFA2T2. Interacts with ZNF652
CC       and ERBB4. May interact with PRKAR2A, PDE7A and probably PDE4A.
CC       Interacts with PLXNA1, PLXNA3 and PRKAR1A (By similarity). Interacts
CC       with HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, NCOR1 and NCOR2. Component of a
CC       TAL-1 complex composed at least of CBFA2T3, LDB1, TAL1 and TCF3.
CC       Interacts with ZBTB4, ZBTB38 and ZBTB33. Interacts with HIF1A and EGLN1
CC       (By similarity). {ECO:0000250|UniProtKB:O75081,
CC       ECO:0000269|PubMed:11533236, ECO:0000269|PubMed:15231665,
CC       ECO:0000269|PubMed:16407974}.
CC   -!- INTERACTION:
CC       O54972; P70662: Ldb1; NbExp=2; IntAct=EBI-8006703, EBI-6272082;
CC       O54972; P22091: Tal1; NbExp=11; IntAct=EBI-8006703, EBI-8006437;
CC       O54972; Q60722: Tcf4; NbExp=2; IntAct=EBI-8006703, EBI-310070;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:10022820}.
CC       Nucleus, nucleoplasm {ECO:0000269|PubMed:10022820}. Golgi apparatus
CC       membrane {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O54972-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O54972-2; Sequence=VSP_028626, VSP_028627;
CC   -!- TISSUE SPECIFICITY: Widely expressed with higher expression in heart,
CC       brain, lung and spleen. Expressed in hematopoietic cells (at protein
CC       level). {ECO:0000269|PubMed:10022820, ECO:0000269|PubMed:15231665}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during embryogenesis from 7 to 17 dpc.
CC       {ECO:0000269|PubMed:10022820}.
CC   -!- INDUCTION: Up-regulated during hematopoietic differentiation.
CC       {ECO:0000269|PubMed:17533052}.
CC   -!- DOMAIN: Nervy homology region 2 (NHR2) mediates homo- and possibly
CC       heterotypic oligomerization by forming a four-helix bundle tetrameric
CC       structure. {ECO:0000250|UniProtKB:Q06455}.
CC   -!- SIMILARITY: Belongs to the CBFA2T family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC28426.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF038029; AAB92651.1; -; mRNA.
DR   EMBL; AK033680; BAC28426.1; ALT_FRAME; mRNA.
DR   EMBL; BC055951; AAH55951.1; -; mRNA.
DR   CCDS; CCDS22744.1; -. [O54972-1]
DR   CCDS; CCDS52696.1; -. [O54972-2]
DR   RefSeq; NP_001103343.1; NM_001109873.1.
DR   RefSeq; NP_033954.2; NM_009824.2.
DR   RefSeq; NP_796263.1; NM_177289.1. [O54972-2]
DR   AlphaFoldDB; O54972; -.
DR   BMRB; O54972; -.
DR   SMR; O54972; -.
DR   BioGRID; 198523; 2.
DR   IntAct; O54972; 5.
DR   MINT; O54972; -.
DR   STRING; 10090.ENSMUSP00000118997; -.
DR   iPTMnet; O54972; -.
DR   PhosphoSitePlus; O54972; -.
DR   MaxQB; O54972; -.
DR   PaxDb; O54972; -.
DR   PRIDE; O54972; -.
DR   ProteomicsDB; 290109; -. [O54972-1]
DR   ProteomicsDB; 290110; -. [O54972-2]
DR   Antibodypedia; 30813; 136 antibodies from 27 providers.
DR   DNASU; 12398; -.
DR   Ensembl; ENSMUST00000006525; ENSMUSP00000006525; ENSMUSG00000006362. [O54972-2]
DR   GeneID; 12398; -.
DR   KEGG; mmu:12398; -.
DR   UCSC; uc009ntl.2; mouse. [O54972-1]
DR   UCSC; uc009ntm.2; mouse. [O54972-2]
DR   CTD; 863; -.
DR   MGI; MGI:1338013; Cbfa2t3.
DR   VEuPathDB; HostDB:ENSMUSG00000006362; -.
DR   eggNOG; ENOG502QTD6; Eukaryota.
DR   GeneTree; ENSGT00950000183176; -.
DR   HOGENOM; CLU_022077_2_0_1; -.
DR   InParanoid; O54972; -.
DR   OrthoDB; 334242at2759; -.
DR   BioGRID-ORCS; 12398; 5 hits in 74 CRISPR screens.
DR   ChiTaRS; Cbfa2t3; mouse.
DR   PRO; PR:O54972; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; O54972; protein.
DR   Bgee; ENSMUSG00000006362; Expressed in internal carotid artery and 189 other tissues.
DR   ExpressionAtlas; O54972; baseline and differential.
DR   Genevisible; O54972; MM.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0030851; P:granulocyte differentiation; ISO:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IGI:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:1903715; P:regulation of aerobic respiration; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 1.20.120.1110; -; 1.
DR   InterPro; IPR013289; CBFA2T1/2/3.
DR   InterPro; IPR013292; CBFA2T3.
DR   InterPro; IPR014896; NHR2.
DR   InterPro; IPR037249; TAFH/NHR1_dom_sf.
DR   InterPro; IPR003894; TAFH_NHR1.
DR   InterPro; IPR002893; Znf_MYND.
DR   PANTHER; PTHR10379; PTHR10379; 1.
DR   Pfam; PF08788; NHR2; 1.
DR   Pfam; PF07531; TAFH; 1.
DR   Pfam; PF01753; zf-MYND; 1.
DR   PRINTS; PR01875; ETOFAMILY.
DR   PRINTS; PR01878; MTG16PROTEIN.
DR   SMART; SM00549; TAFH; 1.
DR   SUPFAM; SSF158553; SSF158553; 1.
DR   PROSITE; PS51119; TAFH; 1.
DR   PROSITE; PS01360; ZF_MYND_1; 1.
DR   PROSITE; PS50865; ZF_MYND_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Differentiation; Golgi apparatus;
KW   Membrane; Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Repressor; Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..620
FT                   /note="Protein CBFA2T3"
FT                   /id="PRO_0000307174"
FT   DOMAIN          146..241
FT                   /note="TAFH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00440"
FT   ZN_FING         533..569
FT                   /note="MYND-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   REGION          1..412
FT                   /note="Mediates localization to the nucleus"
FT   REGION          1..84
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          112..140
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          120..217
FT                   /note="Interaction with ZBTB33"
FT                   /evidence="ECO:0000250|UniProtKB:O75081"
FT   REGION          151..243
FT                   /note="Interaction with HIF1A"
FT                   /evidence="ECO:0000250|UniProtKB:O75081"
FT   REGION          256..321
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          334..354
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          371..389
FT                   /note="Nervy homology region 2 (NHR2); essential for down-
FT                   regulation of PFKFB3, PFKFB4 and PDK1 expression"
FT                   /evidence="ECO:0000250|UniProtKB:O75081"
FT   REGION          419..447
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          462..510
FT                   /note="Nervy homology region 3 (NHR3); essential for down-
FT                   regulation of PFKFB3, PFKFB4 and PDK1 expression"
FT                   /evidence="ECO:0000250|UniProtKB:O75081"
FT   REGION          462..483
FT                   /note="Mediates interaction with PRKAR2A"
FT                   /evidence="ECO:0000250"
FT   REGION          577..620
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          465..520
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        49..64
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        261..289
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        604..620
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         533
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         536
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         544
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         547
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         553
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         557
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         565
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         569
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   MOD_RES         603
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75081"
FT   MOD_RES         607
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75081"
FT   VAR_SEQ         1..35
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_028626"
FT   VAR_SEQ         76..101
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_028627"
FT   CONFLICT        150
FT                   /note="S -> N (in Ref. 1; AAB92651)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        164
FT                   /note="S -> N (in Ref. 1; AAB92651)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   620 AA;  68032 MW;  78DC1995BE365E43 CRC64;
     MSQASTTTLE SGALLSGPRG LQYGSPAHRK EKAAAMPDSP AEVKTQPRST PPSMPPPPPT
     SSQGATRPPS FTPHTHGEDG PATSLPHGRF HGCLKWSMVC LLMNGSSHSP TAIHGAPSTP
     NGFSNGPATS STASLSTQHL PPACGARQLS KLKRFLTTLQ QFGSDISPEI GERVRTLVLG
     LVNSTLTIEE FHAKLQEATN FPLRPFVIPF LKANLPLLQR ELLHCARLAK QTPAQYLAQH
     EQLLLDASAT SPVDSSELLL EVNENGKRRT PDRTKENGSD RDPLHPDHLS KRSCTLSPAQ
     RCSPSNGLPH PTPPPPPHYR LEDMAMAHHF RDSYRHPDPR ELRERHRPLA IPGSRQEEVI
     DHRLTEREWA EEWKHLNSLL NCIMDMVEKT RRSLTVLRRC QEADREELNH WIRCYSDSEE
     GKKGPTPISA RSLNSCSGPE GSQLDVHRDF TPRTLSGYMP EEIWRKAEEA VNEVKRQAMS
     ELQKAVSDAE RKAHELITTE RAKMERALAE AKRQASEDAL TVINQQEDSS ESCWNCGRKA
     SETCSGCNAA RYCGSFCQHK DWEKHHHVCG QSLQGPAAAV ADPLPGQPDA TASPSEAGSA
     GPSRPCSPGP PGPLDAAVPR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024